|
|
|
Opt-in for Free Newsletter, special discount
offers, drugs information & latest pharmacy news.
|
 |
|
Erectile Dysfunction Market in Japan is Currently Dominated
10 Apr 2006
DUBLIN, Ireland--(BUSINESS WIRE)--April 10, 2006 - Research
and Markets has announced the addition of Erectile
Dysfunction Drugs in Japan: Marketing Issues and Strategies to their
offering. Japan - the second largest single-country pharmaceutical market
in the world - represents a very large and relatively untapped erectile
dysfunction (ED) therapeutic market. After providing an overview of the
ED landscape in Japan, this report examines why promotional campaigns
for the ED drugs available in Japan have failed to generate the level
of sales that would be expected given ED therapies' track record in other
markets and the potential patient population in Japan.
Decision Resources hypothesize that, instead of helping alleviate any
stigma attached to ED in Japan, manufacturers' campaigns have actually
exacerbated the challenge. Business Implications -- A complex regulatory
system and dramatic cultural differences from the West make Japan a difficult
target for drug marketers, especially when it comes to controversial indications
such as erectile dysfunction. Drugmakers need to remain mindful of cultural
factors throughout the marketing process.
Source: http://www.pharmalive.com/News/index.cfm?articleid=330162&categoryid=10 |
